IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 337 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $656 | +28.6% | 13,759 | +17.0% | 0.02% | +27.8% |
Q1 2024 | $510 | -22.4% | 11,756 | -9.4% | 0.02% | -21.7% |
Q4 2023 | $657 | -100.0% | 12,982 | -96.0% | 0.02% | -90.8% |
Q1 2016 | $13,252,000 | -28.1% | 327,220 | +9.9% | 0.25% | -33.7% |
Q4 2015 | $18,439,000 | – | 297,739 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |